1 Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.

2 Cost-effectiveness of measles treatment: a systematic review.

3 Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.

4 [Prevention of measles outbreak in National Orphans House. Published in Revista Chilena de Pediatría the year 1933].

5 Immunological efficacy of Vaccination against Measles in Children with Down syndrome

6 Development of a high-throughput assay to measure measles neutralizing antibodies.

7 Letter to the editor: Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections

8 Indirect costs associated with deaths of children aged 0-14 years from measles in a weak health system and conflict and fragile zone: the case of Somalia.

9 Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis.

10 Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.

11 Progress Toward Measles Elimination - China, January 2013-June 2019.

12 Resurgence of measles in the United States: how did we get here?

13 The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus.

14 Factors affecting the infant antibody response to measles immunisation in Entebbe-Uganda

15 Persistent measles infection in malnourished children

16 Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers

17 Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia

18 The Burden of Acute Respiratory Infection Due to Measles in Developing Countries and the Potential Impact of Measles Vaccine

19 Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine

20 Effectiveness of Measles Vaccine given simultaneously with DTP

21 Long-Term Persistence of Mumps Antibody after Receipt of 2 Measles-Mumps-Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University Population

22 Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses

23 Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi

24 Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples

25 The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas.

26 Human immunology of measles virus infection

27 Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi

28 The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants

29 Demonstration of immunoglobulin in brains of ferrets inoculated with an SSPE strain of measles virus: Use of protein a conjugated to horseradish peroxidase

30 Effectiveness of measles vaccine given simultaneously with DTP

31 Immunization against measles in children at risk for severe disease

32 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and re-vaccination

33 The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas

34 The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants

35 The Influence of HIV-1 Exposure and Infection on Levels of Passively Acquired Antibodies to Measles Virus in Zambian Infants

36 Malnutrition and seroconversion following measles immunization

37 Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population

38 Immune responses to measles and smallpox vaccinations in malnourished children

39 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

40 Malnutrition and Seroconversion Following Measles Immunization

41 An evaluation of factors associated with the depression of immunity in malnutrition and in measles

42 Factors affecting the infant antibody response to measles immunisation in Entebbe-Uganda

43 Neonatal Measles Immunity in Rural Kenya: The Influence of HIV and Placental Malaria Infections on Placental Transfer of Antibodies and Levels of Antibody in Maternal and Cord Serum Samples

44 Immunization against measles in children at risk for severe disease

45 Persistent measles infection in malnourished children.

46 Response to live attenuated measles vaccine in children with severe kwashiorkor

47 Possible Interruption of Measles Virus Transmission, Uganda, 2006–2009

48 Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine

49 Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population

50 Factors affecting the infant antibody response to measles immunisation in Entebbe-Uganda

51 Possible interruption of measles virus transmission, Uganda, 2006-2009

52 human parvovirus b19 infections among exanthematic diseases notified as measles

53 freqüência de sarampo, rubéola, dengue e eritema infeccioso entre casos suspeitos de sarampo e rubéola no estado de pernambuco, no período de 2001 a 2004 frequency of measles, rubella, dengue and erythema infectiosum among suspected cases of measles and rubella in the state of pernambuco between 2001 and 2004

54 re-evaluation of the basic procedures involved in the storage of measles vaccine in public health units of the municipality of niterói, state of rio de janeiro, brazil

55 the risk factors of pneumonia disesase at babies under five years old based on measles imune status and breast freeding exclusive status

56 cotreatment of congenital measles with vitamin a and intravenous immunoglobulin

57 acute measles encephalitis in partially vaccinated adults.

58 development of a high-throughput assay to measure measles neutralizing antibodies.

59 evaluation of protection from measles in a cohort of infants through serial estimation of measles antibodies from birth to 9 months

60 selective translation of the measles virus nucleocapsid mrna by la protein

61 elimination of measles from india: challenges ahead and the way forward

62 seroprevalence of measles antibodies and predictors for seropositivity among chinese children

63 cytoskeletal dynamics: concepts in measles virus replication and immunomodulation

64 avaliação das condições de estocagem de vacinas vivas, atenuadas contra o sarampo, em postos de vacinação credenciados e em centros de saúde do estado de são paulo (brasil) an assessment of the storage conditions of live, attenuated vaccines against measles, in authorized vaccination centers and in health services in s. paulo state (brazil)

65 gender differentials in the timing of measles vaccination in rural india

66 mr/mmr vaccine in measles control: a case of missed opportunity?

67 natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas

68 prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, rio grande do sul, brazil, 1996 prevalencia de anticuerpos contra sarampión, paperas y rubéola en niños en edad escolar antes y después de la vacunación con tres vacunas triples antivirales combinadas diferentes, rio grande do sul, brasil, 1996

69 benign recurrent sixth (abducens) nerve palsy following measles-mumps-rubella vaccination

70 Isoelectric point restriction of cerebrospinal fluid and serum IgG antibodies to measles virus polypeptides in multiple sclerosis

71 Studies on leukocyte cultures in measles. II. Detection of measles virus antigen in human leucocytes by immunofluorescence

72 Factors affecting the infant antibody response to measles immunisation in Entebbe-Uganda - BMC Public Health

73 A characteristic cell in nasal secretions during prodromal measles

74 Cell fusion induced by ERVWE1 or measles virus causes cellular senescence

75 Effects of measles on the immune response of Nigerian children

76 Prolonged giant cell excretion in severe African measles

77 Comparison of the Immunogenicity of a Local Measles Vaccine and Other Nominal Vaccines

78 Observation of the Immuno-Pathogenetic State of Measles in Adults

Keyword Connections

Journals

Research Groups

Bibliographies